Intrinsic Value Partners, LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
Intrinsic Value Partners, LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$484,919
-9.6%
50,355
-0.1%
0.62%
-7.8%
Q2 2023$536,309
-1.2%
50,405
-2.3%
0.68%
-7.9%
Q1 2023$542,885
+84330.0%
51,605
-0.6%
0.73%
-16.6%
Q4 2022$643
-99.9%
51,905
-3.5%
0.88%
+13.7%
Q3 2022$557,000
-10.7%
53,805
-0.6%
0.77%
-2.8%
Q2 2022$624,000
-8.9%
54,105
-0.7%
0.80%
+9.6%
Q1 2022$685,000
+6.7%
54,479
-1.0%
0.73%
+6.1%
Q4 2021$642,00055,0570.68%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders